Cedars-Sinai has officially announced the appointment of Peter Slavin as the next president and CEO of Cedars-Sinai Medical Center and Cedars-Sinai Health System.
Slavin will assume the new position with effect from 1 October 2024.
The decision comes after a comprehensive national search to find a successor for the retiring Thomas Priselac, who has dedicated 45 years to Cedars-Sinai, including 30 years in his role as president and CEO.
An expert in academic medicine, Slavin is set to lead Cedars-Sinai following a distinguished tenure at Massachusetts General Hospital in the US, where he has served as president since 2003.
Under his leadership, Massachusetts General, a Harvard teaching hospital, experienced significant expansion in clinical care, scientific impact, research funding, workforce development, and fundraising.
During his time at the hospital, Slavin also contributed to the academic field as a professor of healthcare policy at Harvard Medical School and taught internal medicine.
He stepped down from his position at Massachusetts General in 2021 to explore healthcare investment, consulting, and advising opportunities.
Besides, Slavin has played a key role in representing hospitals nationally, serving as the chair of the board of the Association of American Medical Colleges.
Additionally, he is an elected member of both the National Academy of Medicine and the American Academy of Arts & Sciences.
On accepting the new role at Cedars-Sinai, Slavin said: “I am humbled to follow in Tom Priselac’s footsteps. He has been one of my heroes as I’ve watched Cedars-Sinai’s progress over the years from 2,700 miles away. It is an incredible honour to join Cedars-Sinai and to do my part to build on the organisation’s growth and success.”
Cedars-Sinai, a non-profit academic medical centre in the US, features 886 licensed beds, 2,100 physicians, around 2,800 nurses, and various other healthcare professionals and staff.
Cedars-Sinai Medical Center board of directors chair David Kaplan said: “We express our profound gratitude to Tom Priselac for his remarkable leadership in building Cedars-Sinai into an internationally recognised name in healthcare, and we warmly welcome Dr Slavin to Cedars-Sinai family.”
